| 00:00:00 | Nanoparticle characterization within the drug delivery industry |
| 00:01:36 | Characterization of Nanoparticles within the drug delivery industry |
| 00:01:44 | Contents |
| 00:02:11 | Contents |
| 00:02:15 | Why Consider a Drug Delivery System? |
| 00:02:50 | Example of a drug delivery system |
| 00:04:19 | Candidate Drug Delivery Materials |
| 00:05:26 | Properties of NPs for Nanoscale Drug Delivery |
| 00:06:04 | Nanoparticle Size is the Key Parameter |
| 00:07:00 | Contents |
| 00:07:14 | Nanoparticle tracking analysis (NTA) |
| 00:07:36 | Particles are Visualised Directly, in Real Time |
| 00:07:36 | NTA: Principle of Measurement |
| 00:07:36 | Particle Sizing in Action - Software Analysis |
| 00:07:36 | NTA detection limits |
| 00:08:58 | Contents |
| 00:09:15 | Zetasizer Nano Series |
| 00:10:28 | Dynamic Light Scattering |
| 00:12:13 | Zeta Potential |
| 00:14:26 | Electrophoretic Light Scattering |
| 00:15:48 | Size and Concentration Limits* |
| 00:17:22 | Contents |
| 00:17:38 | Optimising microreactor parameters |
| 00:19:54 | NTA assessment of sucrose in poly-DNA stability |
| 00:21:25 | NTA assessment of sucrose in poly-DNA stability |
| 00:22:29 | NTA assessment of poly-DNA stability for retinal diseases |
| 00:23:44 | NTA sizing of NP mycophenolic acid |
| 00:25:28 | NTA assessment in production and storage of nano-pro-drug |
| 00:27:52 | Contents |
| 00:28:10 | Microemulsions |
| 00:28:43 | Microemulsions |
| 00:30:23 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:31:07 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:32:02 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:33:08 | Functionalised Silica Nanoparticles |
| 00:34:09 | Functionalised Silica Nanoparticles |
| 00:35:06 | Functionalised Silica Nanoparticles |
| 00:36:04 | Functionalised Silica Nanoparticles |
| 00:36:50 | Conclusions |
| 00:37:24 | Further Information |
| 00:37:53 | Many thanks for your attentionAny questions? |
| 00:48:59 | Contact Information |
Various systems have been studied as candidate vehicles for drug delivery, including liposomes, microemulsions, surfactant micelles and functionalized nanoparticles. This webinar will discuss the physical characterization of such samples with reference to various application studies highlightlighting the use of Nanoparticle Tracking Analysis (NTA) and Zetasizer Nano instrumentation in the drug delivery industry.